Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Diabetes duration, glycemic control, and risk of stroke and stroke subtypes: a nationwide prospective cohort study
Xiang Gao1, Huan-Huan Yang2, Fei Xie3
1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
To evaluate the relationship of diabetes duration and glycemic control with risk of stroke and its major subtypes using data from the UK Biobank, a large population-based cohort of UK adults. We included 23,401 UK adult residents with diabetes who had no known stroke at baseline (2006-2010). Diabetes duration was self-reported and glycemic control was assessed by glycated hemoglobin (HbA1c) levels. Their associations with incident stroke were assessed using multivariate Cox models. During a median follow-up of 11.6 years, 982 incident cases of stroke were identified. A longer diabetes duration was associated with higher risk of total stroke, ischemic stroke (IS), and hemorrhagic stroke (HS) (≥ 15 vs. <5 years: HRs [95% CI] were 1.81 [1.50, 2.19], 1.80 [1.47, 2.20], and 2.17 [1.46, 3.23], respectively), while higher levels of HbA1c were associated with higher risk of total stroke and IS but not HS (≥ 8.0% vs. <7.0%: HRs [95% CI] were 1.78 [1.52, 2.09], 1.93 [1.63, 2.28], and 0.97 [0.67, 1.41], respectively). Diabetes duration interacted with glycemic status on total stroke and IS (both P-for-interaction values < 0.01). Individuals who had the longest diabetes duration (≥ 15 years) and poorer glycemic control (≥ 8.0%) had particularly higher risk of total stroke (HR = 3.21; 95% CI: 2.55, 4.04) and IS (HR = 3.47; 95% CI: 2.73, 4.40) as compared with those who had a duration of < 5 years with HbA1c < 8%. A longer diabetes duration and poorer glycemic control were both associated with higher risk of total stroke and IS, and the risk may be further exacerbated with the coexistence of both risk factors.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

